PARP Inhibitors and Prostate Cancer: To Infinity and BeyondBRCA is a research paper published in The Oncologist (2020). On theSindex it has a DataRank of 0. It has been cited 97 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Grant: Center for Cancer Research, National Cancer Institute, National Institutes of Health ZIA BC 010547
Intramural NIH HHS
Grant: ZIA BC010547
FWCI
3.75
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Pharmacogenetics in Italy: current landscape and future prospects
Additional file 2 of Pharmacogenetics in Italy: current landscape and future prospects
Additional file 1 of Pharmacogenetics in Italy: current landscape and future prospects
Additional file 1 of Pharmacogenetics in Italy: current landscape and future prospects